T. Rowe Price Associates
TTOO

T. Rowe Price Associates’s T2 Biosystems, Inc TTOO Stock Holding History

T. Rowe Price Associates’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-68
Closed -$3.33M – 2537
2016
Q1 		$3.33M Sell
68
-26
-28% -$1.15M ﹤0.01% 1447
2015
Q4 		$5.15M Hold
94
– – ﹤0.01% 1414
2015
Q3 		$4.1M Buy
94
+1
+1% +$66.4K ﹤0.01% 1464
2015
Q2 		$7.59M Buy
93
+22
+31% +$1.91M ﹤0.01% 1408
2015
Q1 		$5.5M Buy
+71
New +$6.59M ﹤0.01% 1458

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates's TTOO Position: Q2 2016 in Review

T. Rowe Price Associates sold out of T2 Biosystems, Inc (TTOO) in Q2 2016, closing a stake of 68 shares — an estimated $3.33M sold.

T. Rowe Price Associates first reported a position in TTOO in Q1 2015 and held it in 5 quarters. The position peaked at $7.59M in Q2 2015. 48 funds tracked by Wall St. Rank hold TTOO as of Q2 2016.

  • T. Rowe Price Associates reported no remaining T2 Biosystems, Inc position as of Q2 2016 after selling out during the quarter.
  • T. Rowe Price Associates sold 68 T2 Biosystems, Inc shares in Q2 2016, an estimated $3.33M.
  • T. Rowe Price Associates first reported a position in T2 Biosystems, Inc in Q1 2015 and held it in 5 quarters.
  • T. Rowe Price Associates's T2 Biosystems, Inc position peaked at $7.59M in Q2 2015.
  • 48 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2016.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.